Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
Vol. 7 No. 8, August 2006
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kays, D. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kays, D. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

NeoReviews Vol.7 No.8 2006 e428
© 2006 American Academy of Pediatrics

Congenital Diaphragmatic Hernia

Real Improvements in Survival

David W. Kays, MD*

* Associate Professor of Surgery, University of Florida, Gainesville, Fla

The first 300 words of the full text of this article appear below.


    Objectives
 
After completing this article, readers should be able to:

  1. List the anomalies associated with congenital diaphragmatic hernia (CDH).
  2. Delineate methods of determining the severity of CDH.
  3. Review the roles of exogenous surfactant, extracorporeal membrane oxygenation, inhaled nitric oxide, sildenafil, and gentle ventilation in the management of CDH.
  4. Describe the surgical repair undertaken in CDH.


    Introduction
 
Congenital diaphragmatic hernia (CDH) is an intellectually fascinating and challenging birth defect that too often results in tragic loss for the child and family. Frequently diagnosed ultrasonographically at 20 weeks’ gestation, the diagnosis can overwhelm affected parents who never knew the condition existed and seldom can understand it adequately. Affected newborns face myriad potential issues, including pulmonary insufficiency, pulmonary hypertension, hemodynamic instability, associated cardiac defects, eventual feeding difficulties, and significant risk of dying or of surviving with substantial morbidity. Well-meaning but often inadequately informed physicians and caregivers too frequently view the situation as either hopeless or requiring dramatic but completely unproven prenatal interventions. However, improvements in understanding of CDH physiology coupled with expanding recognition of the negative effects of previously standard postnatal therapies have led to dramatic improvements in CDH survival in many centers. Some argue that the impact on overall CDH survival from these "advances" has been nil, but this is, in large part, due to continued significant rates of pregnancy termination with this diagnosis, rapid adoption of adjuvant CDH treatments, and slower penetration of fundamental changes in CDH therapy.

This review examines what is known of the etiology of CDH, details the factors that affect the severity of the condition, describes the pathophysiology facing affected newborns, defines the physiologic basis of modern treatment, and provides examples of the improved survival and outcome experienced at centers that have embraced certain fundamental concepts.


    Epidemiology and Etiology
 
A relatively common birth defect, CDH is estimated to occur once in every . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Academy of Pediatrics.